SCVNEWS.comMannKind Tops Decade Effort With U.S. Approval of InsulinBloombergMannKind Corp. (MNKD) won U.S. approval to sell its inhaled insulin, culminating an almost decade-long effort, with a warning that the product shouldn’t be used by those with asthma or a serious lung disease. The Food and Drug Administration said today it …FDA approves Afrezza, a new inhaled insulinThe Westside StoryFDA approves inhalable diabetes drug AfrezzaMaryville Daily TimesUS regulator approves Afrezza inhalable insulinLos Angeles TimesNew York Times -The Vergeall 114 news articles …Read Full Story
MannKind Tops Decade Effort With U.S. Approval of Insulin - Bloomberg
Real Estate of Cebu
